interferon beta-1b (betaseron) Report issue

Biologics Recombinant protein Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.   Wikipedia

More Chemistry
actimmune | betaferon | betaseron | extavia | immukin | interf b 1b | interferon beta 1-a | interferon beta 1b | interferon beta-1b | interferon-beta-1b | interferon beta 1b (recombinant) | interferon beta-1b,recombinant | recombinant interferon beta-1b

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue